English
简体中文
Total: £ 56.28
Published Date: 2025-11-05 | Pages: 171 | Tables: 173 | Medical Care
The global ADME DMPK Studies market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is used to assess the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate. This information is essential for understanding how a drug will behave in the body and for designing safe and effective clinical trials.
DMPK studies can be performed in vitro or in vivo. In vitro DMPK studies are typically used to screen a large number of compounds for their ADME properties and to identify promising candidates for further development. In vivo DMPK studies are typically performed later in drug development, after a compound has been shown to have promising ADME properties in vitro.
From a downstream perspective, Pharmaceutical Companies accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
ADME DMPK Studies leading manufacturers including Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, etc., dominate supply; the top five capture approximately % of global revenue, with Charles River leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global ADME DMPK Studies market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Charles River
Labcorp
Eurofins Scientific
PPD
Inotiv
ChemPartner
Evotec
Medicilon
Crown Bioscience
Jubilant Biosys
Creative Biolabs
Allucent
Sai Life Sciences
Sygnature Discovery
Q2 Solutions
Invitrocue
Frontage
BioDuro-Sundia
Wuxi AppTec
Pharmaron
JOINN Laboratories
Tigermed
Segment by Type
In Vitro
In Vivo
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the ADME DMPK Studies study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to ADME DMPK Studies: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global ADME DMPK Studies Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 In Vitro
1.2.3 In Vivo
1.3 Market Segmentation by Application
1.3.1 Global ADME DMPK Studies Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global ADME DMPK Studies Revenue Estimates and Forecasts 2020-2031
2.2 Global ADME DMPK Studies Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global ADME DMPK Studies Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global ADME DMPK Studies Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 In Vitro Market Size by Players
3.3.2 In Vivo Market Size by Players
3.4 Global ADME DMPK Studies Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global ADME DMPK Studies Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global ADME DMPK Studies Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America ADME DMPK Studies Market Size by Type (2020-2031)
6.4 North America ADME DMPK Studies Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America ADME DMPK Studies Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe ADME DMPK Studies Market Size by Type (2020-2031)
7.4 Europe ADME DMPK Studies Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe ADME DMPK Studies Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific ADME DMPK Studies Market Size by Type (2020-2031)
8.4 Asia-Pacific ADME DMPK Studies Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific ADME DMPK Studies Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America ADME DMPK Studies Market Size by Type (2020-2031)
9.4 Central and South America ADME DMPK Studies Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America ADME DMPK Studies Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa ADME DMPK Studies Market Size by Type (2020-2031)
10.4 Middle East and Africa ADME DMPK Studies Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa ADME DMPK Studies Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Business Overview
11.1.3 Charles River ADME DMPK Studies Product Features and Attributes
11.1.4 Charles River ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.1.5 Charles River ADME DMPK Studies Revenue by Product in 2024
11.1.6 Charles River ADME DMPK Studies Revenue by Application in 2024
11.1.7 Charles River ADME DMPK Studies Revenue by Geographic Area in 2024
11.1.8 Charles River ADME DMPK Studies SWOT Analysis
11.1.9 Charles River Recent Developments
11.2 Labcorp
11.2.1 Labcorp Corporation Information
11.2.2 Labcorp Business Overview
11.2.3 Labcorp ADME DMPK Studies Product Features and Attributes
11.2.4 Labcorp ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.2.5 Labcorp ADME DMPK Studies Revenue by Product in 2024
11.2.6 Labcorp ADME DMPK Studies Revenue by Application in 2024
11.2.7 Labcorp ADME DMPK Studies Revenue by Geographic Area in 2024
11.2.8 Labcorp ADME DMPK Studies SWOT Analysis
11.2.9 Labcorp Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Corporation Information
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific ADME DMPK Studies Product Features and Attributes
11.3.4 Eurofins Scientific ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.3.5 Eurofins Scientific ADME DMPK Studies Revenue by Product in 2024
11.3.6 Eurofins Scientific ADME DMPK Studies Revenue by Application in 2024
11.3.7 Eurofins Scientific ADME DMPK Studies Revenue by Geographic Area in 2024
11.3.8 Eurofins Scientific ADME DMPK Studies SWOT Analysis
11.3.9 Eurofins Scientific Recent Developments
11.4 PPD
11.4.1 PPD Corporation Information
11.4.2 PPD Business Overview
11.4.3 PPD ADME DMPK Studies Product Features and Attributes
11.4.4 PPD ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.4.5 PPD ADME DMPK Studies Revenue by Product in 2024
11.4.6 PPD ADME DMPK Studies Revenue by Application in 2024
11.4.7 PPD ADME DMPK Studies Revenue by Geographic Area in 2024
11.4.8 PPD ADME DMPK Studies SWOT Analysis
11.4.9 PPD Recent Developments
11.5 Inotiv
11.5.1 Inotiv Corporation Information
11.5.2 Inotiv Business Overview
11.5.3 Inotiv ADME DMPK Studies Product Features and Attributes
11.5.4 Inotiv ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.5.5 Inotiv ADME DMPK Studies Revenue by Product in 2024
11.5.6 Inotiv ADME DMPK Studies Revenue by Application in 2024
11.5.7 Inotiv ADME DMPK Studies Revenue by Geographic Area in 2024
11.5.8 Inotiv ADME DMPK Studies SWOT Analysis
11.5.9 Inotiv Recent Developments
11.6 ChemPartner
11.6.1 ChemPartner Corporation Information
11.6.2 ChemPartner Business Overview
11.6.3 ChemPartner ADME DMPK Studies Product Features and Attributes
11.6.4 ChemPartner ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.6.5 ChemPartner Recent Developments
11.7 Evotec
11.7.1 Evotec Corporation Information
11.7.2 Evotec Business Overview
11.7.3 Evotec ADME DMPK Studies Product Features and Attributes
11.7.4 Evotec ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.7.5 Evotec Recent Developments
11.8 Medicilon
11.8.1 Medicilon Corporation Information
11.8.2 Medicilon Business Overview
11.8.3 Medicilon ADME DMPK Studies Product Features and Attributes
11.8.4 Medicilon ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.8.5 Medicilon Recent Developments
11.9 Crown Bioscience
11.9.1 Crown Bioscience Corporation Information
11.9.2 Crown Bioscience Business Overview
11.9.3 Crown Bioscience ADME DMPK Studies Product Features and Attributes
11.9.4 Crown Bioscience ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.9.5 Crown Bioscience Recent Developments
11.10 Jubilant Biosys
11.10.1 Jubilant Biosys Corporation Information
11.10.2 Jubilant Biosys Business Overview
11.10.3 Jubilant Biosys ADME DMPK Studies Product Features and Attributes
11.10.4 Jubilant Biosys ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Creative Biolabs
11.11.1 Creative Biolabs Corporation Information
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs ADME DMPK Studies Product Features and Attributes
11.11.4 Creative Biolabs ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.11.5 Creative Biolabs Recent Developments
11.12 Allucent
11.12.1 Allucent Corporation Information
11.12.2 Allucent Business Overview
11.12.3 Allucent ADME DMPK Studies Product Features and Attributes
11.12.4 Allucent ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.12.5 Allucent Recent Developments
11.13 Sai Life Sciences
11.13.1 Sai Life Sciences Corporation Information
11.13.2 Sai Life Sciences Business Overview
11.13.3 Sai Life Sciences ADME DMPK Studies Product Features and Attributes
11.13.4 Sai Life Sciences ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.13.5 Sai Life Sciences Recent Developments
11.14 Sygnature Discovery
11.14.1 Sygnature Discovery Corporation Information
11.14.2 Sygnature Discovery Business Overview
11.14.3 Sygnature Discovery ADME DMPK Studies Product Features and Attributes
11.14.4 Sygnature Discovery ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.14.5 Sygnature Discovery Recent Developments
11.15 Q2 Solutions
11.15.1 Q2 Solutions Corporation Information
11.15.2 Q2 Solutions Business Overview
11.15.3 Q2 Solutions ADME DMPK Studies Product Features and Attributes
11.15.4 Q2 Solutions ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.15.5 Q2 Solutions Recent Developments
11.16 Invitrocue
11.16.1 Invitrocue Corporation Information
11.16.2 Invitrocue Business Overview
11.16.3 Invitrocue ADME DMPK Studies Product Features and Attributes
11.16.4 Invitrocue ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.16.5 Invitrocue Recent Developments
11.17 Frontage
11.17.1 Frontage Corporation Information
11.17.2 Frontage Business Overview
11.17.3 Frontage ADME DMPK Studies Product Features and Attributes
11.17.4 Frontage ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.17.5 Frontage Recent Developments
11.18 BioDuro-Sundia
11.18.1 BioDuro-Sundia Corporation Information
11.18.2 BioDuro-Sundia Business Overview
11.18.3 BioDuro-Sundia ADME DMPK Studies Product Features and Attributes
11.18.4 BioDuro-Sundia ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.18.5 BioDuro-Sundia Recent Developments
11.19 Wuxi AppTec
11.19.1 Wuxi AppTec Corporation Information
11.19.2 Wuxi AppTec Business Overview
11.19.3 Wuxi AppTec ADME DMPK Studies Product Features and Attributes
11.19.4 Wuxi AppTec ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.19.5 Wuxi AppTec Recent Developments
11.20 Pharmaron
11.20.1 Pharmaron Corporation Information
11.20.2 Pharmaron Business Overview
11.20.3 Pharmaron ADME DMPK Studies Product Features and Attributes
11.20.4 Pharmaron ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.20.5 Pharmaron Recent Developments
11.21 JOINN Laboratories
11.21.1 JOINN Laboratories Corporation Information
11.21.2 JOINN Laboratories Business Overview
11.21.3 JOINN Laboratories ADME DMPK Studies Product Features and Attributes
11.21.4 JOINN Laboratories ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.21.5 JOINN Laboratories Recent Developments
11.22 Tigermed
11.22.1 Tigermed Corporation Information
11.22.2 Tigermed Business Overview
11.22.3 Tigermed ADME DMPK Studies Product Features and Attributes
11.22.4 Tigermed ADME DMPK Studies Revenue and Gross Margin (2020-2025)
11.22.5 Tigermed Recent Developments
12 ADME DMPK StudiesIndustry Chain Analysis
12.1 ADME DMPK Studies Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 ADME DMPK Studies Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global ADME DMPK Studies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global ADME DMPK Studies Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global ADME DMPK Studies Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global ADME DMPK Studies Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global ADME DMPK Studies Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global ADME DMPK Studies Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global ADME DMPK Studies Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global ADME DMPK Studies Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global ADME DMPK Studies by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADME DMPK Studies as of 2024)
Table 11. Global ADME DMPK Studies Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global ADME DMPK Studies Companies Headquarters
Table 13. Global ADME DMPK Studies Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global ADME DMPK Studies Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global ADME DMPK Studies Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global ADME DMPK Studies Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global ADME DMPK Studies Revenue by Application (2026-2031) & (US$ Million)
Table 21. ADME DMPK Studies High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America ADME DMPK Studies Growth Accelerators and Market Barriers
Table 25. North America ADME DMPK Studies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe ADME DMPK Studies Growth Accelerators and Market Barriers
Table 27. Europe ADME DMPK Studies Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific ADME DMPK Studies Growth Accelerators and Market Barriers
Table 29. Asia-Pacific ADME DMPK Studies Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America ADME DMPK Studies Investment Opportunities and Key Challenges
Table 31. Central and South America ADME DMPK Studies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa ADME DMPK Studies Investment Opportunities and Key Challenges
Table 33. Middle East and Africa ADME DMPK Studies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Charles River Corporation Information
Table 35. Charles River Description and Major Businesses
Table 36. Charles River Product Features and Attributes
Table 37. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Charles River Revenue Proportion by Product in 2024
Table 39. Charles River Revenue Proportion by Application in 2024
Table 40. Charles River Revenue Proportion by Geographic Area in 2024
Table 41. Charles River ADME DMPK Studies SWOT Analysis
Table 42. Charles River Recent Developments
Table 43. Labcorp Corporation Information
Table 44. Labcorp Description and Major Businesses
Table 45. Labcorp Product Features and Attributes
Table 46. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Labcorp Revenue Proportion by Product in 2024
Table 48. Labcorp Revenue Proportion by Application in 2024
Table 49. Labcorp Revenue Proportion by Geographic Area in 2024
Table 50. Labcorp ADME DMPK Studies SWOT Analysis
Table 51. Labcorp Recent Developments
Table 52. Eurofins Scientific Corporation Information
Table 53. Eurofins Scientific Description and Major Businesses
Table 54. Eurofins Scientific Product Features and Attributes
Table 55. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Eurofins Scientific Revenue Proportion by Product in 2024
Table 57. Eurofins Scientific Revenue Proportion by Application in 2024
Table 58. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 59. Eurofins Scientific ADME DMPK Studies SWOT Analysis
Table 60. Eurofins Scientific Recent Developments
Table 61. PPD Corporation Information
Table 62. PPD Description and Major Businesses
Table 63. PPD Product Features and Attributes
Table 64. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. PPD Revenue Proportion by Product in 2024
Table 66. PPD Revenue Proportion by Application in 2024
Table 67. PPD Revenue Proportion by Geographic Area in 2024
Table 68. PPD ADME DMPK Studies SWOT Analysis
Table 69. PPD Recent Developments
Table 70. Inotiv Corporation Information
Table 71. Inotiv Description and Major Businesses
Table 72. Inotiv Product Features and Attributes
Table 73. Inotiv Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Inotiv Revenue Proportion by Product in 2024
Table 75. Inotiv Revenue Proportion by Application in 2024
Table 76. Inotiv Revenue Proportion by Geographic Area in 2024
Table 77. Inotiv ADME DMPK Studies SWOT Analysis
Table 78. Inotiv Recent Developments
Table 79. ChemPartner Corporation Information
Table 80. ChemPartner Description and Major Businesses
Table 81. ChemPartner Product Features and Attributes
Table 82. ChemPartner Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. ChemPartner Recent Developments
Table 84. Evotec Corporation Information
Table 85. Evotec Description and Major Businesses
Table 86. Evotec Product Features and Attributes
Table 87. Evotec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Evotec Recent Developments
Table 89. Medicilon Corporation Information
Table 90. Medicilon Description and Major Businesses
Table 91. Medicilon Product Features and Attributes
Table 92. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Medicilon Recent Developments
Table 94. Crown Bioscience Corporation Information
Table 95. Crown Bioscience Description and Major Businesses
Table 96. Crown Bioscience Product Features and Attributes
Table 97. Crown Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Crown Bioscience Recent Developments
Table 99. Jubilant Biosys Corporation Information
Table 100. Jubilant Biosys Description and Major Businesses
Table 101. Jubilant Biosys Product Features and Attributes
Table 102. Jubilant Biosys Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Jubilant Biosys Recent Developments
Table 104. Creative Biolabs Corporation Information
Table 105. Creative Biolabs Description and Major Businesses
Table 106. Creative Biolabs Product Features and Attributes
Table 107. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Creative Biolabs Recent Developments
Table 109. Allucent Corporation Information
Table 110. Allucent Description and Major Businesses
Table 111. Allucent Product Features and Attributes
Table 112. Allucent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Allucent Recent Developments
Table 114. Sai Life Sciences Corporation Information
Table 115. Sai Life Sciences Description and Major Businesses
Table 116. Sai Life Sciences Product Features and Attributes
Table 117. Sai Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Sai Life Sciences Recent Developments
Table 119. Sygnature Discovery Corporation Information
Table 120. Sygnature Discovery Description and Major Businesses
Table 121. Sygnature Discovery Product Features and Attributes
Table 122. Sygnature Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Sygnature Discovery Recent Developments
Table 124. Q2 Solutions Corporation Information
Table 125. Q2 Solutions Description and Major Businesses
Table 126. Q2 Solutions Product Features and Attributes
Table 127. Q2 Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Q2 Solutions Recent Developments
Table 129. Invitrocue Corporation Information
Table 130. Invitrocue Description and Major Businesses
Table 131. Invitrocue Product Features and Attributes
Table 132. Invitrocue Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Invitrocue Recent Developments
Table 134. Frontage Corporation Information
Table 135. Frontage Description and Major Businesses
Table 136. Frontage Product Features and Attributes
Table 137. Frontage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Frontage Recent Developments
Table 139. BioDuro-Sundia Corporation Information
Table 140. BioDuro-Sundia Description and Major Businesses
Table 141. BioDuro-Sundia Product Features and Attributes
Table 142. BioDuro-Sundia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. BioDuro-Sundia Recent Developments
Table 144. Wuxi AppTec Corporation Information
Table 145. Wuxi AppTec Description and Major Businesses
Table 146. Wuxi AppTec Product Features and Attributes
Table 147. Wuxi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Wuxi AppTec Recent Developments
Table 149. Pharmaron Corporation Information
Table 150. Pharmaron Description and Major Businesses
Table 151. Pharmaron Product Features and Attributes
Table 152. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Pharmaron Recent Developments
Table 154. JOINN Laboratories Corporation Information
Table 155. JOINN Laboratories Description and Major Businesses
Table 156. JOINN Laboratories Product Features and Attributes
Table 157. JOINN Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. JOINN Laboratories Recent Developments
Table 159. Tigermed Corporation Information
Table 160. Tigermed Description and Major Businesses
Table 161. Tigermed Product Features and Attributes
Table 162. Tigermed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Tigermed Recent Developments
Table 164. Raw Materials Key Suppliers
Table 165. Distributors List
Table 166. Market Trends and Market Evolution
Table 167. Market Drivers and Opportunities
Table 168. Market Challenges, Risks, and Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. ADME DMPK Studies Product Picture
Figure 2. Global ADME DMPK Studies Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. In Vitro Product Picture
Figure 4. In Vivo Product Picture
Figure 5. Global ADME DMPK Studies Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceutical Companies
Figure 7. Medical Device Companies
Figure 8. Others
Figure 9. ADME DMPK Studies Report Years Considered
Figure 10. Global ADME DMPK Studies Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 12. Global ADME DMPK Studies Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global ADME DMPK Studies Revenue Market Share by Region (2020-2031)
Figure 14. Global ADME DMPK Studies Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. In Vitro Revenue Market Share by Player in 2024
Figure 17. In Vivo Revenue Market Share by Player in 2024
Figure 18. Global ADME DMPK Studies Revenue Market Share by Type (2020-2031)
Figure 19. Global ADME DMPK Studies Revenue Market Share by Application (2020-2031)
Figure 20. North America ADME DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players ADME DMPK Studies Revenue (US$ Million) in 2024
Figure 22. North America ADME DMPK Studies Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America ADME DMPK Studies Revenue (US$ Million) by Application (2020-2031)
Figure 24. US ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 25. Canada ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 27. Europe ADME DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players ADME DMPK Studies Revenue (US$ Million) in 2024
Figure 29. Europe ADME DMPK Studies Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe ADME DMPK Studies Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 32. France ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 34. Italy ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 35. Russia ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific ADME DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players ADME DMPK Studies Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific ADME DMPK Studies Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific ADME DMPK Studies Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 41. Japan ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 43. Australia ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 44. India ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore ADME DMPK Studies Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America ADME DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players ADME DMPK Studies Revenue (US$ Million) in 2024
Figure 52. Central and South America ADME DMPK Studies Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America ADME DMPK Studies Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil ADME DMPK Studies Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina ADME DMPK Studies Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa ADME DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players ADME DMPK Studies Revenue (US$ Million) in 2024
Figure 58. South America ADME DMPK Studies Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa ADME DMPK Studies Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries ADME DMPK Studies Revenue (2020-2025) & (US$ Million)
Figure 61. Israel ADME DMPK Studies Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt ADME DMPK Studies Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa ADME DMPK Studies Revenue (2020-2025) & (US$ Million)
Figure 64. ADME DMPK Studies Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
